Fuso Pharmaceutical Industries,Ltd.
4538 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 大阪市中央区道修町一丁目７番１０号
- Website:
- https://www.fuso-pharm.co.jp/en/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Fuso Pharmaceutical Industries, Ltd. is a leading Japanese pharmaceutical company dedicated to enhancing health and well-being through innovative medical solutions. With a commitment to "Supporting Life, Nurturing Life," Fuso focuses on research and development to produce high-quality pharmaceuticals that address various health needs. The company aims to contribute to society by developing effective treatments and advancing healthcare standards. Through a combination of scientific expertise and a strong ethical foundation, Fuso Pharmaceutical Industries strives to improve patient outcomes and support the overall health of communities both in Japan and globally.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-26 04:32 |
Inside Information Statement
臨時報告書
|
Japanese | 27.4 KB | |
| 2025-06-24 08:02 |
Internal Control over Financial Reporting
内部統制報告書－第102期(2024/04/01－2025/03/31)
|
Japanese | 25.2 KB | |
| 2025-06-24 08:01 |
Regulatory News Service
確認書
|
Japanese | 9.4 KB | |
| 2025-06-24 08:00 |
Annual Report
有価証券報告書－第102期(2024/04/01－2025/03/31)
|
Japanese | 1.0 MB | |
| 2025-06-03 10:03 |
Inside Information Statement
臨時報告書
|
Japanese | 22.6 KB | |
| 2025-05-28 09:44 |
Inside Information Statement
臨時報告書
|
Japanese | 23.6 KB | |
| 2024-11-12 07:02 |
Regulatory News Service
確認書
|
Japanese | 9.3 KB | |
| 2024-11-12 07:01 |
Interim Report
半期報告書－第102期(2024/04/01－2025/03/31)
|
Japanese | 189.2 KB | |
| 2024-06-26 03:18 |
Inside Information Statement
臨時報告書
|
Japanese | 24.7 KB | |
| 2024-06-25 09:19 |
Internal Control over Financial Reporting
内部統制報告書－第101期(2023/04/01－2024/03/31)
|
Japanese | 24.1 KB | |
| 2024-06-25 09:17 |
Regulatory News Service
確認書
|
Japanese | 9.4 KB | |
| 2024-06-25 09:04 |
Annual Report
有価証券報告書－第101期(2023/04/01－2024/03/31)
|
Japanese | 1019.3 KB | |
| 2024-05-13 10:14 |
Inside Information Statement
臨時報告書
|
Japanese | 23.1 KB | |
| 2024-03-27 09:07 |
Inside Information Statement
臨時報告書
|
Japanese | 23.9 KB | |
| 2024-02-13 06:18 |
Regulatory News Service
訂正有価証券届出書（組込方式）
|
Japanese | 173.2 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Nippon Shinyaku Co.,Ltd. | Japan | 4516 | |
|
Noile-Immune Biotech Inc. | Japan | 4893 | |
|
Novartis AG | Switzerland | NOVN | |
|
Nur Ink Innovations Ltd. | Israel | NURI | |
|
Nxera Pharma Co., Ltd. | Japan | 4565 | |
|
ObsEva SA | Switzerland | OBSN | |
|
ODI Pharma AB | Sweden | ODI | |
|
Oncolys BioPharma Inc. | Japan | 4588 | |
|
OncoTherapy Science, Inc. | Japan | 4564 | |
|
OncoZenge AB | Sweden | ONCOZ |